Lonza Peptides is a CDMO of peptides based in USA (NH) / Switzerland. Direct manufacturer. Founded 1897. Key products include Peptide APIs, Oligonucleotides.
Listing reviewed August 2026.
Swiss CDMO with US (NH) operations. World leader in peptide and oligonucleotide CDMO services. GMP manufacturing with full analytical testing and regulatory support. Provides comprehensive batch documentation and COAs.
Lonza Peptides is listed as a CDMO in the peptide supply chain, serving North America markets from USA (NH) / Switzerland. As a direct manufacturer, this supplier controls its own production process from synthesis through purification and quality control release testing. Verification is based on publicly available information and cross-referenced against industry databases. This supplier has a strong confidence score, indicating a high level of verification and reliability for B2B sourcing.